by Crestone, Inc. | Jul 29, 2022 | Information
Clostridium difficile infection (CDI) is a gastrointestinal condition caused by toxin-producing strains of C. difficile bacteria. Commonly referred to as C. diff infection, this illness is a result of an excess of the Clostridioides difficile bacterium (also referred...
by Crestone, Inc. | Jul 21, 2022 | Information
Clostridioides difficile is a bacterium that is found in the intestines of humans and animals and in the environment. Certain strains of this organism can produce toxins that cause damage to the colon of humans resulting in diarrhea known as C. difficile infection or...
by Crestone, Inc. | Jun 28, 2022 | Events
2022 ASM Microbe Presentation Details Oral Session: In vivo Pharmacodynamic Evaluation of CRS0540 in the Murine Thigh and Lung Infection Models against Staphylococcus aureus Poster: Potency of the Novel PolC DNA Polymerase Inhibitor CRS0540 in a Disseminated Listeria...
by Crestone, Inc. | Jun 27, 2022 | Events
Crestone Presents at the Colorado Mycobacteria Conference 2022: Focus on NTM Poster Presentations: In vitro Activity and Mode of Action of CRS0393, a Potent MmpL3 Inhibitor as a Novel Antimycobacterial Agent Pharmacokinetics of a Novel Antimycobacterial Agent,...
by Crestone, Inc. | Jun 27, 2022 | Events
ECCMID 2022 Presentation Details Crestone presents at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal. Oral Session: Discovery of CRS0393, a Potent MmpL3 Inhibitor as a Novel Antimycobacterial...
